[미국] Diagnosis or prognosis of lung cancer and colorectal cancer based on expression level of glutaredoxin 3 (글루타레독신 3의 발현 수준에 기초가 된 폐암과 직장결장암의 진단 또는 예후)

판매 대리인 : 기율특허

전화번호 : 02-782-1004

메일주소 : kiyul@kiyul.co.kr

판매특허요약 : [미국] Diagnosis or prognosis of lung cancer and colorectal cancer based on expression level of glutaredoxin 3 (글루타레독신 3의 발현 수준에 기초가 된 폐암과 직장결장암의 진단 또는 예후)

가격 : 가격 협의

SKU: 배재대학교 산학협력단 카테고리:

출원번호 : 13259918 (2009.04.15)

등록번호 : 09128095 (2015.09.08)

특허권자 : Paichai University Industry-Academic Cooperation Foundation

요약 :

The present invention relates to a biomarker for diagnosing lung cancer and colorectal cancer containing glutaredoxin 3 as an active ingredient, and a kit for diagnosing lung cancer and colorectal cancer using the same biomarker. Glutaredoxin 3 of the present invention is over-expressed in lung cancer tissue and colorectal cancer tissue, which enables early prediction of diagnosis or prognosis of lung cancer and colorectal cancer. Thus, glutaredoxin 3 can be helpfully used as a biomarker for diagnosing lung cancer and colorectal cancer.